135 related articles for article (PubMed ID: 12731575)
21. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
Schäfer K; Albert ED; Rodt H; Thierfelder S
Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
[TBL] [Abstract][Full Text] [Related]
22. [Differences in the capacity of HLA sera to react with T- and B-lymphocyte populations].
Zotikov EA; Tananov AT
Biull Eksp Biol Med; 1976 Jun; 81(6):698-9. PubMed ID: 60152
[TBL] [Abstract][Full Text] [Related]
23. Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system.
Duquesnoy RJ; Zeevi A; Marrari M; Halim K
Clin Immunol Immunopathol; 1982 May; 23(2):254-68. PubMed ID: 6179667
[No Abstract] [Full Text] [Related]
24. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease.
McNeil AJ; Yap PL; Gore SM; Brettle RP; McColl M; Wyld R; Davidson S; Weightman R; Richardson AM; Robertson JR
QJM; 1996 Mar; 89(3):177-85. PubMed ID: 8731561
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
[TBL] [Abstract][Full Text] [Related]
26. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
Radvany RM; Patel KM
Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
[TBL] [Abstract][Full Text] [Related]
27. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
[TBL] [Abstract][Full Text] [Related]
28. Detection of B-cell-specific alloantibodies in pregnancy sera in the lymphocytotoxicity and the indirect immunofluorescence techniques.
Décary F; van Helden-Henningheim L; van Griethuysen D; Helmerhorst FM; van der Werf AJ; Engelfriet CP
Tissue Antigens; 1979 Jul; 14(1):1-9. PubMed ID: 91215
[TBL] [Abstract][Full Text] [Related]
29. Natural HLA antibodies.
Tongio MM; Falkenrodt A; Mitsuishi Y; Urlacher A; Bergerat JP; North ML; Mayer S
Tissue Antigens; 1985 Nov; 26(5):271-85. PubMed ID: 3879021
[TBL] [Abstract][Full Text] [Related]
30. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
[TBL] [Abstract][Full Text] [Related]
32. Dilutions and specificity analysis of pretransplant sera.
Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
[TBL] [Abstract][Full Text] [Related]
33. [Cross-reactivity of HLA antigens of the donor and patient--a cause of unsuccessful thrombocyte transfusion in patients with HLA antibodies].
Májský A
Bratisl Lek Listy; 1989 Apr; 90(4):286-9. PubMed ID: 2765960
[TBL] [Abstract][Full Text] [Related]
34. Recurrent erythema multiforme: tissue typing in a large series of patients.
Schofield JK; Tatnall FM; Brown J; McCloskey D; Navarrete C; Leigh IM
Br J Dermatol; 1994 Oct; 131(4):532-5. PubMed ID: 7947205
[TBL] [Abstract][Full Text] [Related]
35. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera.
Feighery CF; Stastny P
Immunogenetics; 1980; 10(1):31-8. PubMed ID: 6157642
[TBL] [Abstract][Full Text] [Related]
36. Human alloimmune sera against T cell subsets. Detection and influence on pokeweed mitogen-stimulated Ig production in vitro.
van Leeuwen A; Festenstein H; van Rood JJ
J Exp Med; 1980 Aug; 152(2 Pt 2):235s-242s. PubMed ID: 6447743
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
Feighery CF; Stastny P
Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
[TBL] [Abstract][Full Text] [Related]
38. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
[TBL] [Abstract][Full Text] [Related]
39. Increased frequency of HLA-DRw3 in systemic lupus erythematosus.
Celada A; Barras C; Benzonana G; Jeannet M
Tissue Antigens; 1980 Mar; 15(3):283-8. PubMed ID: 6970425
[TBL] [Abstract][Full Text] [Related]
40. HLA-A, B, C and DR antigens in immunoglobulin A deficiency.
Hammarström L; Smith CI
Tissue Antigens; 1983 Jan; 21(1):75-9. PubMed ID: 6601317
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
